Nanoporous Cu Prepared through Dealloying by Selectively Etching an Alkaline Metal with Saline
Source abstract
Abstract
A facile, benign, and rapid dealloying method was employed to synthesize nanoporous Cu using an ammonium chloride (NH 4 Cl) saline solution and Mg as an etchant and a sacrificial metal, respectively. The large difference between the standard electrode potentials of Mg and Cu (−2.36 and +0.34 V, respectively) resulted in rapid etching at 10 nm/min and 303 K. Dealloying for 15 min yielded a nanoporous Cu foil, exhibiting a specific surface area of 24.1 m 2 /g. The raw materials Mg and NH 4 Cl are naturally abundant; Mg is classified as a biodegradable metal, while NH 4 Cl is recognized as a safe material by the United States Food and Drug Administration. No harmful byproducts were produced during dealloying. Therefore, the proposed dealloying method is environmentally benign and addresses the issue of the hazardous chemical waste produced via conventional electrochemical dealloying methods.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoporous metals and alloys · Electrocatalysts for Energy Conversion · Supercapacitor Materials and Fabrication
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Robotics, Tohoku University, Room 113, Building No. A15, Area A01, 6-6-01 Aoba, Aramakiaza, Aobaku, Sendaishi, Miyagi 980-8579, Japan
Funding
Japan Society for the Promotion of Science · JKA Foundation · Uehara Memorial Foundation
References (31)
Show source-provided references
1. 10.1002/adma.20190082610.1002/adma.201900826 ↗
2. 10.1038/nnano.2011.1310.1038/nnano.2011.13 ↗
3. 10.1021/acsami.7b1870810.1021/acsami.7b18708 ↗
4. 10.1038/ncomms316910.1038/ncomms3169 ↗
5. 10.1039/C8TA04495C10.1039/C8TA04495C ↗
6. 10.1021/acscatal.6b0361310.1021/acscatal.6b03613 ↗
7. 10.1039/C7NR06254K10.1039/C7NR06254K ↗
8. 10.1016/j.nanoen.2019.02.02010.1016/j.nanoen.2019.02.020 ↗
9. 10.1021/acsenergylett.9b0237410.1021/acsenergylett.9b02374 ↗
10. 10.1002/adma.20200773310.1002/adma.202007733 ↗
11. 10.1002/adma.20160140910.1002/adma.201601409 ↗
12. 10.1021/jp811445a10.1021/jp811445a ↗
13. 10.1021/acsami.5b1124410.1021/acsami.5b11244 ↗
14. 10.1038/s41467-017-02167-y10.1038/s41467-017-02167-y ↗
15. 10.1002/adfm.20180540210.1002/adfm.201805402 ↗
16. 10.1021/jp014384710.1021/jp0143847 ↗
17. 10.1002/ep.1198210.1002/ep.11982 ↗
18. 10.1002/adma.20130630410.1002/adma.201306304 ↗
19. 10.1038/nature1649210.1038/nature16492 ↗
20. 10.1126/science.122632510.1126/science.1226325 ↗
21. Foof, U. S.; Drug Administration Department of Health and Human Services, Code of federal regulations Title 21. 1983. Title 21,
22. 10.1021/la062313z10.1021/la062313z ↗
23. 10.1038/srep3608410.1038/srep36084 ↗
24. 10.1351/pac19855704060310.1351/pac198557040603 ↗
25. 10.1016/j.marpetgeo.2016.09.00110.1016/j.marpetgeo.2016.09.001 ↗
26. 10.1073/pnas.191883711710.1073/pnas.1918837117 ↗
27. 10.1002/anie.20180964610.1002/anie.201809646 ↗
28. 10.1126/sciadv.aas945910.1126/sciadv.aas9459 ↗
29. 10.1038/srep0287810.1038/srep02878 ↗
30. 10.1016/j.corsci.2010.08.00510.1016/j.corsci.2010.08.005 ↗
31. 10.1039/B919313H10.1039/B919313H ↗